Phase I – Bioequivalence

295 trials 18 recruiting

Filter these 295 trials by condition, country, sponsor and more.

Open in Search →

Bioequivalence study of the oral suspension of netupitant/palonosetron combination product versus the hard capsules of netupitant/palonosetr… Not authorised

2023-504355-28-00 Healthy volunteers
Open label, four-period, two-sequence, fully replicated, randomized, single dose pivotal study for the assessment of bioequivalence between … Not authorised

2023-505335-12-00 Not applicable. The study will be conducted on healthy
A study to investigate the pharmacokinetics and safety of KM04 compared to US-Gonal-f RFF Redi-ject and EU-Gonal-f in healthy adult female v… Not authorised

2025-523368-19-00 Functional female infertility
Randomised, crossover bioequivalence clinical trial of edoxaban 60 mg film-coated tablets, after a single oral dose administration to health… Pending

2022-502085-24-00 Edoxaban is used as antithrombotic agents, but it is a
A Randomized, Multiple-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY03010 and the Relative Bioavaila… Pending

2023-508981-13-00 Schizophrenia
Bioequivalence study of two sulodexide preparations: Sulodexide Intexo 250 LRU and Vessel Due F 250 LRU cps Pending

2024-515605-26-00 No medical condition.
Bioequivalence of two transdermal therapeutic systems delivering 100 mcg/h fentanyl Pending

2024-517506-29-00 Bioequivalence trial in healthy volunteers
Bioequivalence of Lisdexamfetamine dimesylate 10 mg Capsules in Healthy Participants Under Fasting Conditions. Pending

2024-517732-21-00 No medical condition.
A double blinded, balanced, randomized, two-treatment, two-period, two-sequence, single dose, crossover, bioequivalence study comparing Lisd… Pending

2024-517956-36-00 ADHD
Etude de bioéquivalence entre Circadin et Melatonin PILEJE LP 2 mg Pending

2024-519932-17-00 Primary insomnia characterized by poor quality of sleep
An open label, balanced, randomized, two-treatment, four-period, two-sequence, single-dose, crossover fully replicate bioequivalence study c… Pending

2025-520618-76-00 ulcerative colitis
A study understanding how much CDR132L enters the bloodstream after injection under the skin compared to injection into a vein in healthy p… Pending

2025-521329-34-00 Healthy volunteers, treatment for heart failure
A double blinded, balanced, randomized, two-treatment, four-period, two-sequence, single-dose, crossover fully replicate bioequivalence stud… Pending

2025-521598-16-00 ulcerative colitis
A double blinded, balanced, randomized, two-treatment, four-period, two-sequence, single-dose, crossover fully replicate bioequivalence stud… Pending

2025-522106-20-00 ulcerative colitis
A Phase 1, Randomized, Double-Blind, Two-Arm, Two-Way Crossover Study of Pharmacokinetics and Pharmacodynamics of QL0911 Pending

2025-523355-59-00 Immune Thrombocytopenia, Hematopoietic Syndrome of Acut
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover, bioavailability study comparing Bupropi… Pending

2025-523410-84-00 Seasonal affective disorder
An open label, randomized, multiple-dose, two-treatment, two-period, cross-over bioequivalence study comparing Pyridostigmine Bromide, P.R.T… Pending

2025-524219-35-00 treatment of myasthenia gravis
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover bioequivalence study comparing Trametin… Pending

2025-524267-20-00 Adjuvant treatment of BRAF V600E or V600K mutation-posi
Bioequivalence study comparing two temazepam 20 mg tablet formulations after fasted administration; an open, randomized, single centre, sing… Pending

2025-524376-36-00 short-term treatment of insomnia
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Imatini… Pending

2025-524935-38-00 Acute Lymphoblastic Leukemia (Ph+ ALL)
A randomized, balanced, two-treatment, two-sequence, single oral dose, two stage crossover adaptative bioequivalence study of Rifaximin 200 … Pending

2025-525078-12-00 healthy subjects
Bioequivalence study 1 to compare pharmacokinetics of Parkinson´s disease drugs in healthy volunteers Pending

2026-525448-14-00 Parkinson disease
A study in healthy people to compare two tablet formulations of pramipexole Pending

2026-525704-98-00 Healthy volunteer trial
A Phase I, open-label study in healthy adults comparing the availability in the body of the active substance lidocaine following administrat… Recruiting

2026-525752-29-00 bioavailability trial with healthy participants, therap 2026-06-01